Remove Development Remove Insulin Remove Packaging
article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

” The Android-powered device can run certified third-party software, initially shipping with a handful of apps including Glytec’s Glucommander insulin-dosing software under the terms of a deal announced today.

Insulin 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sanofi to Invest €40M to Expand Production of Thymoglobulin and Diabetes Drug Tzield at France Site

XTalks

million) will be dedicated to the production and development of a second-generation Thymoglobulin. million) of the investment package will go towards internalizing and localizing the production of monoclonal antibodies for Tzield in France. billion) insulin manufacturing facility at its Frankfurt Höchst campus in Germany.

article thumbnail

MIOTIFY platform for digital health products clears AZ road test

pharmaphorum

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). The next steps?

article thumbnail

This is the Newest Functional Beverage from the Co-Founders of Oatly and Fiji Water

XTalks

Following a soft launch in select markets, the beverage buffs behind Oatly and Fiji Water have teamed up to develop Good Idea , a functional beverage that will soon debut in the US. Formulated with Nordic berries, amino acids, chromium, zinc and electrolytes, Good Idea is free from artificial colors, sweeteners, caffeine and calories.

article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

We’d like to get to a point where our treatment and prevention offering can be packaged together for the NHS – because both go hand in hand, alongside digital tools”. We’d like to get to a point where our treatment and prevention offering can be packaged together – because both go hand in hand, alongside digital tools.”.

article thumbnail

GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook

Roots Analysis

Currently, more than 10 GLP-1 receptor agonists are commercially available, while various molecules are under development for various disease indications. Within clinical stage of development, majority (43) drug candidates are in Phase II of development followed by Phase I (34). per package in the US.